التفاصيل البيبلوغرافية
العنوان: |
Allogeneic hematopoietic cell transplantation for high-risk CLL: 10-year follow-up of the GCLLSG CLL3X trial |
المؤلفون: |
Stephan Stilgenbauer, Sebastian Böttcher, Hartmut Döhner, Ute Hegenbart, Norbert Schmitz, Lutz Uharek, Michael Stadler, Peter Dreger, Isabelle Krämer, Anthony D. Ho, Sascha Dietrich, Christof Scheid, Matthias Zeis, Michael Hallek, Jörg Thomas Bittenbring, Michael Kneba |
المصدر: |
Blood. 130:1477-1480 |
بيانات النشر: |
American Society of Hematology, 2017. |
سنة النشر: |
2017 |
مصطلحات موضوعية: |
Oncology, medicine.medical_specialty, Chronic lymphocytic leukemia, Immunology, Salvage therapy, Biochemistry, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, medicine, Neoplasm, Hematopoietic cell, business.industry, Cell Biology, Hematology, medicine.disease, Transplantation, Leukemia, chemistry, 030220 oncology & carcinogenesis, Ibrutinib, Alemtuzumab, business, 030215 immunology, medicine.drug |
تدمد: |
1528-0020 0006-4971 |
الوصول الحر: |
https://explore.openaire.eu/search/publication?articleId=doi_________::8fbadad1b8b01f25b15055a6900d847aTest https://doi.org/10.1182/blood-2017-04-775841Test |
حقوق: |
OPEN |
رقم الانضمام: |
edsair.doi...........8fbadad1b8b01f25b15055a6900d847a |
قاعدة البيانات: |
OpenAIRE |